Haywood Lowers Tilray Price Target To $7.25
On January 10th, Tilray Inc (TSX: TLRY) reported their fiscal second-quarter financial results. The company saw net revenues of $155.15
Read more
Cannabis
Leafly Delays Merger With Merida SPAC Due To New Financing
It looks like Leafly Holdings will have to wait a little longer to go public. The firm last night announced
Read more
Tilray: Canaccord Cuts Price Target To $9.00
On January 10th, Tilray Inc (TSX: TLRY) reported their fiscal second-quarter financial results, the company saw net revenues of $155.15 million,
Read more
Organigram Reports Q2 2022 Revenues Of $30.4 Million, Positive Gross Margins
Organigram Holdings (TSX: OGI) has finally done it. The company has finally posted a positive gross margin quarter, although just
Read more
Tilray Sees Cannabis Revenues Fall 16.6% In Second Quarter 2022
Tilray Inc (TSX: TLRY) this morning reported its fiscal second quarter results for the period ended November 30, while also
Read more
Sundial Growers Sees Alcanna Shareholders Approve Acquisition
Alcanna Inc (TSX: CLIQ) shareholders have approved the previously announced plan of arrangement with Sundial Growers (NASDAQ: SNDL). The company
Read more
Tilray: Cantor Slashes Price Target To $7.40 Ahead Of Earnings
Tilray (TSX: TLRY) is expected to report its second fiscal quarter 2022 results on January 10 before the markets open.
Read more
Ayr Wellness Buys The December Dip With Share Repurchase Program
It appears that at least one multi-state operator has been buying the dip, so to speak. Ayr Wellness (CSE: AYR.A)
Read more
Sundial Growers Sweetens Deal To Include Cash For Alcanna Shareholders
Sundial Growers (NASDAQ: SNDL) is doing all that it can to salvage its proposed acquisition of Alcanna Inc (TSX: CLIQ).
Read more
Ascend Wellness Continues To Fight Medmen Over New York Asset
After losing its New York investment arrangement with Medmen Enterprises (CSE: MMEN), it appears that Ascend Wellness (CSE: AAWH) is
Read more